Innova Captab Ltd

Innova Captab Limited's Board of Directors met on August 11, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026. The board also adopted amendments to the Policy for Determination of Materiality of Events or Information, aligning it with SEBI regulations. Additionally, the board discussed the revision of financial statements for the quarter and financial year ended March 31, 2026, due to identified inadvertent errors, noting these revisions would not materially impact current or comparative results and would be placed for formal adoption at the next board meeting.

Innova Captab Limited announced its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The company reported a significant year-on-year growth, with Revenue from Operations increasing by 34.0% to ₹470.9 crores compared to ₹351.5 crores in Q1 FY26. EBITDA grew by 32.7% to ₹75.1 crores, with an EBITDA margin of 16.0%. Profit After Tax (PAT) saw a substantial rise of 42.3% to ₹44.1 crores from ₹31.0 crores in the prior year's quarter, resulting in a PAT margin of 9.4%. The company attributes this strong performance to its diversified business model, disciplined execution, and sustained customer traction across its CDMO Services & Products and Branded Generics businesses. The Jammu facility is also witnessing a steady ramp-up.

Innova Captab's consolidated Q1 FY27 (quarter ended 30 June 2026) revenue rose 33.9% YoY to ₹470.9 Cr (₹351.5 Cr a year ago) and 5.2% QoQ (₹447.8 Cr in Q4 FY26). Consolidated PAT climbed 42.3% YoY to ₹44.1 Cr (₹31.0 Cr a year ago) and 15.9% QoQ (₹38.1 Cr in Q4 FY26), with EPS at ₹7.71 versus ₹5.42 a year ago. No exceptional items or minority-interest adjustments were disclosed in either period, so the reported and adjusted YoY growth are the same. Standalone PAT grew faster, +58% YoY to ₹32.1 Cr on revenue of ₹400.5 Cr (+39.5% YoY) — the standalone/consolidated growth rates diverge by more than 10 percentage points, consistent with the subsidiaries (Univentis Medicare, Sharon Bio-Medicine) growing slower than the parent this quarter. Margins expanded on both counts: consolidated net margin rose to 9.37% from 8.71% a year ago and 8.47% last quarter, while operating margin (EBITDA/revenue) improved to roughly 16.0% from 14.8% YoY and 14.5% QoQ. Management's press release frames revenue and EBITDA growth at 34% and 33% YoY respectively — EBITDA growth of ~32.8% calculated here is essentially in line with, not ahead of, revenue growth, even though margins did expand in percentage-point terms; PAT growth (42%) did outpace revenue growth, consistent with the operating-leverage story management laid out. Against the prior (Q4 FY26) concall guidance — 20%+ revenue growth for FY27 with EBITDA/PAT growth outpacing revenue on Jammu ramp-up — this quarter's 34% revenue growth clears the bar comfortably, and PAT growth outpaced revenue as guided; EBITDA growth, however, tracked revenue rather than exceeding it, a partial miss on the specific operating-leverage claim even as absolute margins widened. No formal Street consensus estimate for this quarter could be confirmed, so vsStreet is marked unknown rather than guessed. The quarter's only other disclosed corporate action is the board's parallel move to correct inadvertent errors identified in the FY26 audited standalone and consolidated financial statements approved on 7 May 2026 — the company states this correction has no material impact on the Q1 FY27 results or their comparatives, and a revised FY26 statement is pending at the next board meeting. Management's own framing — "strong start to FY27" driven by steady order flows, a broader product portfolio and deeper customer engagement across CDMO Services & Products and Branded Generics — is broadly borne out by the numbers: both revenue and profit growth accelerated from the year-ago quarter's ~9% net margin base, and sequential (QoQ) growth was also positive rather than a seasonal give-back, since this is a pharma/CDMO business without strong seasonality.

Innova Captab Limited has announced a Board of Directors meeting scheduled for August 11, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Additionally, the board will review and approve revised audited standalone financial results for the quarter and financial year ended March 31, 2026, including cash flow and balance sheet statements. This revision is due to an immaterial inadvertent error. The trading window for designated persons will reopen 48 hours after the declaration of these financial results.

Innova Captab Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut from July 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. The specific date for the Board of Directors' meeting to approve these results will be communicated later. This measure is a standard corporate governance practice to prevent potential insider trading.

Innova Captab Ltd has announced the postponement of its 22nd Annual General Meeting (AGM), originally scheduled for June 29, 2026. The decision was made due to unavoidable circumstances. The company will announce a new date, time, and venue for the AGM in due course, adhering to the Companies Act, 2013, and SEBI regulations. Shareholders will be informed accordingly. The company has expressed regret for any inconvenience caused by this postponement.

Innova Captab Ltd is sending physical copies of its Annual Report 2025-26 to shareholders whose email addresses are not registered with the company or depositories. This action complies with SEBI (LODR) Regulations, 2015, as amended on December 12, 2024. The physical letter will include a web link directing shareholders to the complete Annual Report available on the company's website. This ensures all shareholders can access the required information as per regulatory updates.

Innova Captab Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as required by SEBI regulations. The report details the company's commitment to sustainable growth and value creation, outlining its ESG performance and integration of sustainability principles into its business strategy. Key areas covered include environmental initiatives like carbon emission monitoring, employee welfare and safety programs, corporate social responsibility activities, and a robust corporate governance framework. The report also notes the operational commencement of the Kathua, Jammu facility in January 2025, contributing to higher figures compared to the previous year. The BRSR is available on the company's website.

Innova Captab Limited has announced that its 22nd Annual General Meeting (AGM) will be conducted on Monday, June 29, 2026, at 11:00 AM IST. The meeting will be held virtually via Video Conferencing/Other Audio Visual Means, adhering to MCA and SEBI guidelines. The company will also present its 22nd Integrated Annual Report for the financial year ended March 31, 2026, which includes the Notice of AGM, financial statements (standalone and consolidated), Directors' Report, and Independent Auditors' Report. The report will be emailed to registered members and made accessible via a web link for others. The annual report is also available on the company's website.

Innova Captab Limited has announced its 22nd Annual General Meeting (AGM) scheduled for Monday, June 29, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM) in compliance with regulatory circulars. The company will also be distributing its Integrated Annual Report for the financial year 2025-2026, which includes the Notice of AGM, financial statements, Directors' Report, and Auditors' Report. The report will be emailed to registered members and a web link will be provided to others. The annual report is also available on the company's website.